For people with diabetes, medicaid expansion helps, but can't do it all: BU study

November 24, 2020

Medicaid expansion through the Affordable Care Act has insured millions of low-income people in the United States, improving outcomes for patients with many different diseases. But expansion alone has not been enough to improve outcomes for patients with diabetes, according to a new Boston University School of Public Health (BUSPH) study.

Published in the American Journal of Preventive Medicine, the study finds an increase in insurance coverage, ability to see a physician, and foot examinations among patients with diabetes in states that expanded Medicaid. However, the study did not find significant changes in follow-up examinations, care, or treatment for diabetes, pointing to the need for other structural changes.

"There are likely many steps between having health insurance and successfully getting treatment for diabetes--including providers needing to recognize the importance of screening and patients needing to implement rigorous lifestyle changes," says study lead author Dr. Lily Yan, who was a master of science in population health student at BUSPH while working on the study and is now a global health research fellow at Weill Cornell Medicine.

"While having health insurance through a program like Medicaid expansion may be necessary for better health, it may not be sufficient alone."

The researchers used data from the Behavioral Risk Factor Surveillance System from 2008 through 2018 to compare 24 states that expanded Medicaid as of 2018 and 16 states that had not. The study included all non-pregnant, Medicaid-eligible residents of these states with self-reported diabetes.

The study examined diabetes outcomes using the "continuum of care" model of successful diabetes management: Screening would ideally lead to diagnosis, then linkage to care for the disease, then treatment, and ultimately control of the disease.

The researchers found improvements the beginning of the continuum in the first years following a state's Medicaid expansion: Health insurance coverage rates for people with diabetes increased by 7.2 percentage points, and as a result the ability to afford a physician increased by 5.5 percentage points. This in turn led to a 5.3-percentage point increase in diabetic foot examinations by healthcare providers. A few years after expansion, the researchers also found a 7.2-percentage point increase in self-administered foot examinations.

The researchers also found an increase in linkage to care among Hispanic patients. However, the researchers found no statistically significant improvement overall in linkage to care, lifestyle changes and self-monitoring of conditions, or treatment.

"Medicaid coverage on its own is not enough to manage diabetes. Our policymakers should think about insurance coverage and beyond: supporting behavioral interventions, bolstering healthcare workforces, and addressing the underlying socioeconomic determinants of health," says study senior author Dr. Kiersten Strombotne, assistant professor of health law, policy & management at BUSPH.
-end-
About the Boston University School of Public Health

Founded in 1976, the Boston University School of Public Health is one of the top five ranked private schools of public health in the world. It offers master's- and doctoral-level education in public health. The faculty in six departments conduct policy-changing public health research around the world, with the mission of improving the health of populations--especially the disadvantaged, underserved, and vulnerable--locally and globally.

Boston University School of Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.